Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yixuesheng capsule is a traditional Chinese patent medicine (CPM) used to treat anemia and promote hematopoietic function. It is specifically indicated for iron-deficiency anemia and cancer-related anemia, particularly in patients exhibiting spleen-kidney deficiency syndrome. The formulation typically includes a complex mixture of botanical and animal-derived ingredients, such as *Astragalus membranaceus*, *Angelica sinensis*, *Rehmannia glutinosa*, and *Cervus elaphus* (deer antler). Its therapeutic effects are attributed to its ability to tonify the spleen and kidney, which in traditional Chinese medicine theory are central to blood production. It is often used as supportive therapy for patients with digestive tract tumors or those experiencing bone marrow suppression from chemotherapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yixuesheng capsule.